Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Open Angle Glaucoma: Treatment

Open Angle Glaucoma: Treatment

In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...

Angle Closure Glaucoma: Treatment

Angle Closure Glaucoma: Treatment

Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...

Glaucoma: Overview

Glaucoma: Overview

Glaucoma is an eye condition characterized by increased intraocular pressure that damages the retina and optic nerve, leading to irreversible blindness if left untreated. The human eye has various components, including the cornea, iris, pupil, lens, and optic nerve. Aqueous humor is secreted by the epithelium of the ciliary body in the posterior chamber and flows through the trabecular meshwork and canal of Schlemm, maintaining normal intraocular pressure. The trabecular meshwork and the canal...

Ophthalmic Drug Delivery Systems

Ophthalmic Drug Delivery Systems

Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Longitudinal Visual Field and Quality-of-Life Change in the Treatment for Advanced Glaucoma Study.

Ophthalmology·2026

Same author

Assessment of the level of harm resulting from glaucoma progression due to review delay.

Eye (London, England)·2025

Same author

Emerging perspectives in quality of life after trabeculectomy surgery.

Eye (London, England)·2025

Same author

Which glaucoma patients should be monitored at home and exploration of clinician perceptions on home monitoring? a survey of glaucoma specialists in the UK.

BMJ open·2024

Same author

Validating and Updating the OHTS-EGPS Model Predicting 5-year Glaucoma Risk among Ocular Hypertension Patients Using Electronic Records.

Ophthalmology. Glaucoma·2024

Same author

Feasibility of in-home monitoring for people with glaucoma: the I-TRAC mixed-methods study.

Health technology assessment (Winchester, England)·2024

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Treating patients presenting with advanced glaucoma--should we reconsider current practice?

Anthony J King¹, Richard E Stead, Alan P Rotchford

¹Department of Ophthalmology, Queen's Medical Centre Campus, Nottingham University NHS Hospital, Nottingham NG7 2UH, UK. anthony.king@nuh.nhs.uk

The British Journal of Ophthalmology

|November 25, 2010

Summary

Managing advanced glaucoma is challenging. This review examines evidence for controlling intraocular pressure (IOP) to prevent blindness, considering medical treatments, surgery, and new guidelines suggesting primary surgical intervention for advanced visual field loss.

More Related Videos

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Related Experiment Videos

Last Updated: Jun 6, 2026

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Full-Circle Cauterization of Limbal Vascular Plexus for Surgically Induced Glaucoma in Rodents

Published on: February 15, 2022

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Glaucoma-inducing Procedure in an In Vivo Rat Model and Whole-mount Retina Preparation

Published on: March 12, 2016

Area of Science:

Ophthalmology
Glaucoma Management
Clinical Evidence Review

Background:

Advanced glaucoma with visual field loss poses a significant risk of blindness.
Current UK practice often delays glaucoma surgery until medical treatments fail.
National Institute for Clinical Excellence (NICE) guidelines suggest primary surgery for advanced cases.

Purpose of the Study:

To review the evidence for managing patients with advanced glaucoma.
To evaluate strategies for optimizing intraocular pressure (IOP) control.
To examine the implications of recent NICE guidelines on surgical intervention.

Main Methods:

Literature review of current evidence on advanced glaucoma management.
Analysis of treatment outcomes for medical and surgical interventions.
Examination of clinical guidelines and expert opinions.

Main Results:

Maximizing IOP control is crucial to minimize further visual field deterioration.
Medical management is the current standard, with surgery reserved for treatment failures.
NICE guidelines propose primary surgery, contrasting with prevailing UK ophthalmologist practice.

Conclusions:

The optimal management strategy for advanced glaucoma requires careful consideration of risks and benefits.
Further evidence is needed to support the shift towards primary surgical intervention.
Balancing medical and surgical approaches is key to preventing blindness in advanced glaucoma patients.